Demiraslan, H. Et Al. 2017. Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. MEDICAL MYCOLOGY , vol.55, no.5 , 535-540.

Demiraslan, H., ATALAY, M. A., EREN, E., Demir, K., KAYNAR, L., KOÇ, A. N., ... DOĞANAY, M.(2017). Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. MEDICAL MYCOLOGY , vol.55, no.5, 535-540.

Demiraslan, Hayati Et Al. "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia," MEDICAL MYCOLOGY , vol.55, no.5, 535-540, 2017

Demiraslan, Hayati Et Al. "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia." MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540, 2017

Demiraslan, H. Et Al. (2017) . "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia." MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540.

@article{article, author={Hayati Demiraslan Et Al. }, title={Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia}, journal={MEDICAL MYCOLOGY}, year=2017, pages={535-540} }